Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
News
TYPE
HEADLINE
FILED AT
6-K
Genmab Announces Financial Results for the Nine Months of 2026
6-K
Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First
6-K
Genmab Announces Positive Phase 3 Results for Rina-S in Platinum-Resistant Ovarian Cancer
6-K
Genmab Announces Third Quarter 2026 Net Sales of DARZALEX®
6-K
Genmab A/S Announces Extraordinary General Meeting Resolutions and Grant of Restricted Stock Units to Board Members
6-K
Genmab and AbbVie Announce Positive Phase 3 Results for Epcoritamab Plus R-CHOP in Newly Diagnosed DLBCL
Prospectus
TYPE
HEADLINE
FILED AT
424B4
28,500,000 American Depositary Shares
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SC TO-T/A
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SC TO-T
Form SC TO-T - Tender offer statement by Third Party
